Venous Thromboembolism

Direct oral anticoagulants significantly reduced risk for recurrence of cancer-associated venous thromboembolism compared with dalteparin among patients with cancer, according to study results published in Mayo Clinic Proceedings.

Venous thromboembolism-related hospital readmissions after complex cancer surgery continued to increase beyond 30 days after surgery, according to a multicenter, population-based retrospective study in JAMA Surgery.

Prescriptions dispensed for apixaban beyond 90 days after hospitalization resulted in a lower rate of hospitalization for recurrent venous thromboembolism compared with warfarin beyond 90 days, according to study results published in JAMA.

Patients with venous thromboembolism and obesity had a lower mortality risk than those with normal BMI, according to a study published in Journal of Thrombosis and Haemostasis.

Multiple perioperative and operative factors increased the risk for venous thromboembolism in patients with inflammatory bowel disease, according to a presenter at the European Crohn’s and Colitis Organization.

Shorter vs. standard anticoagulation duration for children with provoked venous thromboembolism.

Milvexian for prevention of venous thromboembolism in patients undergoing total knee arthroplasty.

According to a meta-analysis of three studies, prolonged TV viewing was associated with elevated risk for venous thromboembolism, independent of traditional risk factors, including age, sex, BMI and physical activity.

Among young patients with provoked venous thromboembolism, shorter duration of anticoagulation is noninferior to current standard of care, according to the results of the Kids-DOTT randomized trial.

Use of a universal nutritional screening tool may help identify patients with inflammatory bowel disease who are at high risk for malnutrition and other adverse outcomes, according to data presented at the ACG Annual Scientific Meeting.